Skip to content
Sleep Study Clinical Trials

North Carolina

Sleep disorder clinical trials in North Carolina

24 sleep disorder studies are recruiting participants at sites in 11 cities across North Carolina as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-8925
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse North Carolina by city

Cities with the most studies recruiting right now.

Every North Carolina city with a recruiting study

By research area: Narcolepsy (13), Insomnia (7), Sleep Apnea (4).

Denver (10), Huntersville (10), Charlotte (4), Durham (4), Winston-Salem (4), Morrisville (3), Chapel Hill (1), Fayetteville (1), Fort Bragg (1), Gastonia (1), Wilmington (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Insomnia: recently updated in North Carolina

Basic details from each study's public record (the 12 most recently updated of 24). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps

    • No phase
    • Ages 40 to 75
    • All sexes
    Sponsor
    StudySetGo
    Recruiting in
    Charlotte
    Registry record
    NCT07651514 · updated

Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in North Carolina on ClinicalTrials.gov.

Sleep apnea: recently updated in North Carolina

  1. SUNOSI® (Solriamfetol) Pregnancy Registry

    • Observational
    • All ages
    • Female participants
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Morrisville · Wilmington
    Registry record
    NCT06413420 · updated
  2. Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

    • Observational
    • Ages 8 to 13
    • All sexes
    Sponsor
    University of North Carolina, Chapel Hill
    Recruiting in
    Chapel Hill
    Registry record
    NCT07581938 · updated

Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in North Carolina on ClinicalTrials.gov.

Narcolepsy: recently updated in North Carolina

  1. A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Harmony Biosciences Management, Inc.
    Recruiting in
    Denver · Gastonia · Huntersville
    Registry record
    NCT07675135 · updated
  2. A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 71
    • All sexes
    Sponsor
    Takeda
    Recruiting in
    Denver · Huntersville · Winston-Salem
    Registry record
    NCT07646678 · updated
  3. A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Recruiting in
    Denver · Huntersville
    Registry record
    NCT07598708 · updated
  4. A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Recruiting in
    Denver · Huntersville
    Registry record
    NCT06767683 · updated
  5. A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Takeda
    Recruiting in
    Denver · Huntersville · Winston-Salem
    Registry record
    NCT06952699 · updated
  6. A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Denver · Morrisville
    Registry record
    NCT07625280 · updated
  7. A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Recruiting in
    Charlotte
    Registry record
    NCT07455383 · updated
  8. A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Recruiting in
    Charlotte · Huntersville
    Registry record
    NCT07502443 · updated
  9. A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Recruiting in
    Charlotte
    Registry record
    NCT07540897 · updated

Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-8925

or send a short form

How should we reach you?

Call